UChicago Medicine
A

Understanding CRISPR and Gene Editing in the Treatment of Heme Malignancies and Blood Disorders

By UChicago Medicine FEATURING Alan Cooper
By UChicago Medicine FEATURING Alan Cooper
243 views
July 29, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

12:23
Hematology Content

An ITP Case Study of Treating a Patient Who Was Non-responsive to St…

Feat. J. Bussel

Recommended

21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.4K views
23:17

Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

University of Miami Sylvester Comprehensive Cancer Center

D. Tripathy

620 views
13:07

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Moffitt Cancer Center

J. Chavez

821 views
27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

656 views
16:57

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

678 views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

422 views
33:17

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

613 views
15:22

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

271 views
45:56

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

867 views
35:27

Updates on Management of DLBCL

Louisville Hematology Highlights

J. Leonard

699 views
20:34

Sequencing of Bispecifics With Other Therapies in DLBCL

UChicago Medicine

E. Budde

328 views
10:04

How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…

Tara Graff

477 views
16:25

New

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

180 views
20:18

Will Immune Therapy Replace Transplant in Hematologic Malignancies?

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. Gale

506 views
06:47

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

2.1K views
45:27

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

263 views
08:23

R/R DLBCL Case Discussion: 81 y/o Male Needing 3rd Line Treatment

Total Health

J. Chandler, B. Randolph, M. Onciu

214 views
09:18

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Randomized …

Insights from 2023 ASCO® Annual Meeting

J. Westin

1.5K views
55:10

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

324 views
30:07

Current Management of DLBCL From Frontline to Relapsed Disease

Dipenkumar Modi

325 views
AUTOPLAY